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Abstract:
High throughput methods to measure protein-protein interactions will facilitate 
uncovering pairs of unknown interactions as well as designing new interactions. We have 
developed a platform to detect protein interactions on the surface of yeast, where one 
protein (bait) is covalently anchored to the cell wall and the other (prey) is expressed in 
secretory form. The prey is released either outside of the cells or remains on the cell 
surface by its binding to the bait. The strength of their interaction is measured by 
antibody binding to the epitope tag fused to the prey or direct readout of split 
fluorescence protein complementation. Our novel ‘yeast surface 2-hybrid’ system was 
found to differentiate 6-log difference in binding affinities between coiled coil 
associations and to measure specific interactions of antibodies and antigens. We 
demonstrate the use of YS2H in exploring activation allostery in integrins and isolating 
heavy chain only antibodies against botulinum neurotoxin. 
Introduction
Protein-protein interactions are essential to virtually every cellular process and their 
understanding is of great interest in basic science as well as in the development of 
effective therapeutics. Existing techniques to detect and screen pairs of interacting 
proteins inside cells include the yeast two-hybrid system (Y2H)
1
 and bimolecular 
fluorescence complementation (BiFC)
2-4
, where the association of two interacting 
proteins either turns on a target gene that is necessary for cell survival or leads to the 
emission of green fluorescence protein (GFP) or its variants. The application of protein-
protein interactions that are probed with Y2H and BiFC has been focused mainly on the 
interactions occurring in the nucleus or cytosol. To explore protein-protein interactions 
occurring in the secretory pathway, new methods have been developed that express 
proteins in the bacterial periplasm
5
 or eukaryotic membrane compartments
6, 7
. In other 






 displays provide efficient 
means to couple genotypes and phenotypes of target molecules, and have been used for 
protein engineering, particularly for antibody discovery.
Display systems developed to implement directed evolution and the screening of 
antibody libraries may require exogenous antigens in their soluble form, which can be 
technically challenging if the antigens are hard to express or unstable in solution. By 
coexpressing antibody libraries with antigens in the periplasm of bacteria, a method for 
engineering antibodies has been developed by selecting bacteria based on the amount of 
the epitope-tagged antibody bound to the anchored antigens
5
. However, there is no 
system available to date that is capable of quantitatively exploring the interactions among 
the proteins that need to be expressed via eukaryotic secretory pathway. 
To take advantage of the efficiency of antibody engineering in the yeast display 
system and to circumvent the need for soluble antigens in antibody screening, we have 
designed a yeast surface 2-hybrid (YS2H) system that can express a pair of proteins, one 
protein as a fusion to a yeast cell wall protein, agglutinin, and the other in a secretory 
form. When an interaction between the two proteins in this system occurs, they associate 
in the secretory pathway and the prey that would otherwise be released into the media, is 
captured on the surface by the bait. We have devised two different schemes to 
quantitatively estimate the strength of two interacting molecules: flow cytometric 
detection of the binding of the antibody to the epitope tag that is fused to the prey and 
also the GFP readout from the complementation of split GFP fragments fused to the prey 
and the bait. Herein we demonstrate that YS2H is capable of differentiating the strength 
of protein-protein interactions over 10
6
-fold difference, reports specific interactions 
between antigen and antibody, and isolates hot spots of allosteric activation in integrins. 
Furthermore, we applied YS2H to select for camelid heavy chain only antibodies that 
bind to botulinum neurotoxin (BoNT) light chain proteases and have potential as 




The design of the yeast surface 2-hybrid system (YS2H). YS2H is built on a yeast 
display system
10, 12
, which expresses, under the control of the GAL1 promoter, a protein 
of interest as a fusion to Aga2. Aga2 connects to the -glucan linked Aga1 to form a cell 
wall protein called agglutinin. To extend this methodology to the expression of a pair of 
proteins, we have inserted an additional expression cassette under the GAL10 promoter
13
.
Similar approaches have previously been employed to express heterodimeric mammalian 
proteins (e.g., antibody in Fab format
14
, major histocompatibility complex (MHC) class II 
 and  subunits
15
) on the surface of yeast cells. In our YS2H system, the resulting vector 
(Fig. 1a,b and Supplementary Fig. 1) expresses the bait protein under the GAL10 
promoter as a fusion to Aga2 and the prey protein under the GAL1 promoter. The signal 
sequence used is either that of Aga2 (for the data in Fig. 1) or the -1 mating factor (for 
the data in Figs. 2-3)
16
. Flag and Myc tags are fused to the C-terminal of the bait and prey 
proteins, respectively, and are used to examine the surface expression of the bait and the 
amount of the prey that is bound to the bait. To incorporate the BiFC technique into the 
YS2H system, we inserted the sequence encoding enhanced GFP (eGFP) fragments
2
downstream of the prey (NeGFP contains residues Val-2 to Ala-155) and the bait 
(CeGFP with Asp-156 to Lys-239) to monitor their interaction by GFP readout (Fig.1b). 
To validate that antibody binding to the Myc tag or GFP readout correlates with the 
strength of molecular interactions in YS2H, we expressed several pairs of acid (En) and 
base (Kn) -helices of varying heptad repeats (n) that associate into coiled coils (Fig. 1c). 
These coiled coils have been designed de novo to have affinities (KD) in the range of 100 
pM (E5/K5) to 100 μM (E3/K3) with higher affinity for longer helices through 
hydrophobic interactions at the interface and electrostatic attraction between the 
oppositely charged residues from each helix
17
. A remarkable correlation was observed 
between Myc expression (mean fluorescence intensity or MFI, measured by antibody 
binding to Myc tag) as well as GFP readout vs. the interaction strength, particularly 
within the range of 100 pM to 100 nM KD (Fig. 1d-e). The difference between E4-K4 
and E5-K3, corresponding to the affinity range of 100 nM – 10 μM, was clearly 
discernible with antibody binding to Myc tag, while the GFP readout was capable of 
differentiating the interaction between E5-K3 and E3-K3, corresponding to a 10 μM –
100 μM affinity range.
To test whether the GFP readout can be enhanced with the use of a GFP variant 
that was engineered to fold faster and to be more soluble, we replaced eGFP with OPT-
GFP
18
 that was split either at Ala-155 or at Glu-214, which led to the N- and C-terminal 
fragments consisting of  strands 1-7 and 8-11 or consisting of  strands 1-10 and 11. 
Notably, the intensity of GFP fluorescence increased dramatically, and low affinity 
interactions of 1-100 μM KD led to a level of fluorescence far above the noninduced 
control (Fig. 1f). However, OPT-GFP complementation displayed high level of 
spontaneous complementation (consistent with a prior finding with OPT-GFP fragments 
1-10 and 11
18
), indicated by the fluorescence from the clones that contained only the base 
(K3) without the acid coil (Fig. 1f). We have also observed that while the OPT-GFP N-
terminal fragment is exported to the surface without the complementation with the other 
half, the N-terminal fragment of eGFP without complementation is poorly exported to the 
surface (data not shown). We speculate that eGFP split fragments exist in a misfolded 
state
3
and are routed into the degradation pathway in yeast by the quality control 
machinery of the yeast secretory pathway
19, 20
. In the case of the interaction between the 
base coil fused to NeGFP and the acid coil without fusion (Kn-NeGFP-Flag:En-Myc), the 
amount of the acid coil captured by the base was much lower in comparison to its level 
bound to the base when the base was not fused to NeGFP (Kn-Flag:En-Myc) (first vs. 
third columns in Fig. 1d). This observation provides evidence that the acid base coiled 
coils (or two interacting proteins) fused with split eGFP (Kn-NeGFP-Flag:En-CeGFP-
Myc) should associate in the secretory pathway, causing GFP fragments to complement 
in order to be exported to the surface of the cells (second column in Fig. 1d). This also 
implies that protein-protein interactions occurring on the surface of yeast cells are those 
that are genetically encoded by the same cells, which ensures genotype-phenotype 
linkage for the directed evolution system.
It is important to note as to how GFP complementation in our system was in 
quantitative correlation with the strength of protein-protein interactions, in contrast to a 
previous finding
3
 that although GFP complementation was dependent on two interacting 
proteins, fluorescence intensity was relatively invariant with the affinity of two proteins. 
We believe this discrepancy is due to the fact that in our system two proteins are 
expressed into the secretory pathway and the split GFP molecules without 
complementation are sorted into a degradation pathway or secreted into media. This 
speculation was supported by our finding that when proteins were expressed in the 
cytoplasm by deleting the signal sequence in the YS2H vector, the complementation of 
split GFP that were fused to acid/base coils of E5/K5, E4/K4, and E3/K3 was insensitive 
to their strength of association (Supplementary Fig.4).
YS2H detects specific interactions of antibodies and antigens. To investigate a 
potential use of YS2H for antibody discovery, we examined the interactions of known 
pairs of antigen and antibody. Specifically, we used as a model the integrin lymphocyte 
function-associated antigen (LFA)-1 I domain both wild-type and the high affinity (HA) 
mutant (K287C/K294C)
21
 and single-chain fragment variable (scFv) forms of the 
activation-dependent antibody (AL-57)
22, 23
 and activation-insensitive antibody 
(TS1/22)
24
. The interaction between antigen and antibody was measured by the detection 
of Myc tag fused to the antibody at the C-terminal (Fig. 2a). A tag-based assay was 
chosen to remove the constraint requiring the linker between the antigen/antibody and 
GFP fragments to be optimal, which will depend on the binding site of antibodies to the 
antigens. Antibody binding to Myc tag was detected for clones expressing TS1/22 with 
either the wild-type or the HA I domains (Fig. 2b). In contrast, antibody binding to the 
Myc tag was detected for clones expressing AL-57 along with the HA I domain but not 
with the wild-type I domain. AL-57 is a ligand-mimetic antibody and its binding to the 
LFA-1 I domain depends on the presence of metal ions in the site, known as the metal ion 
dependent adhesion site (MIDAS) at the top of the I domain
25
. This was also confirmed 
by the decrease in the Myc tag expression when ethylene-diamine-tetraacetic acid
(EDTA) was added to the cells expressing AL-57 with the HA I domain (Fig. 2b). The 
presence of EDTA did not affect TS1/22 binding nor alter surface expression of the I 
domains. Therefore, Myc tag expression in our system has accurately reproduced known 
properties of mAb AL-57 and TS1/22.
Due to the fact that antibodies non-covalently associate with antigen in the YS2H 
system, we speculated that antibodies can be induced to dissociate from the cells 
(analogous to eluting antibodies from a Protein A column), thereby facilitating 
subsequent characterization of soluble antibodies in other biochemical and biological 
assays (Fig. 2c). To test this idea, yeast cells expressing TS1/22 and the wild-type I 
domain were pelleted and incubated with dissociation buffer and subsequently adjusted to 
pH 8 with neutralization buffer (see Methods below). Neutralized supernatant was then 
added to cells expressing the wild-type I domain alone (from pCTCON vector containing 
LFA-1 I domain
22
), and anti-Myc antibody binding was examined. The level of anti-Myc 
antibody binding was even higher than the initial expression of the Myc tag, likely due to 
the increase in the concentration of antibodies during elution (see Methods) and the 
difference in the level of I domain expression (Fig. 2c). This highlights an additional 
advantage of the YS2H system, which allows for the convenient and functional elution of 
antibodies from the cell surface for subsequent solution assays. 
To demonstrate that YS2H can be used to isolate activating mutations in antigens 
that exhibit allosteric activation, we have transformed yeast with the error-prone PCR 
products of the LFA-1 wild-type I domain and the YS2H construct containing the cDNA 
encoding AL-57 scFv. The mutagenesis library was then sorted for anti-Myc antibody 
binding using a magnetic affinity cell sorter (MACS). After two rounds of sorting, cells 
were plated to obtain individual clones, from which two unique clones having Myc tag 
expression higher than non-induced background were identified (Fig. 2d). These clones 
were found to contain the mutations of L295P and F265S which were previously 
identified as mildly and highly activating mutations in the LFA-1 I domain, respectively 
22
. A higher level of fluorescence was seen from the F265S mutant than the L295P 
mutant, correlating with their previous classification.
Antibody discovery: VHH against Botulinum neurotoxin protease. Approximately 
half of the IgGs in camelid sera are heavy chain only antibodies devoid of light chains
26, 
27
. Due to the lack of light chains, antigenic specificity of the heavy chain only antibodies 
is limited to a variable domain of the heavy chain (VHH). We are seeking VHH agents 
that bind and inhibit the light chain (LC) protease domains of Botulinum neurotoxins 
(BoNTs) as components in therapeutic agents for the treatment of botulism. In prior work 
(Maass et. al.
27
and manuscript in preparation), we immunized alpacas with BoNT LCs 
of serotype A (A-LC) followed by serotype B (B-LC). We then used phage display 
techniques to identify VHHs from these alpacas with affinity for the BoNT LC proteases 
(manuscript in preparation). We selected two A-LC binding VHHs (B8 and G6) and two 
B-LC binding VHHs (B10 and C3) for testing with the YS2H system (Fig. 3a). Myc tag 
expression was found to be highest in the clone expressing VHH-B8 and BoNT/A-LC, 
while the binding level of the other VHHs was lower (MFI < 10~18), which would 
correspond to affinities in the range of 100 nM to 10 μM, estimated from the Myc 
expression in coiled coil interactions (Fig.1e). 
To compare the use of YS2H to conventional phage display screening, a yeast 
antibody library was constructed by transforming cells with the YS2H plasmid containing 
the alpaca immune cDNA library as prey and the BoNT/B-LC gene as bait. Yeast cells 
enriched after two-rounds of MACS sorting with anti-Myc antibody began to show an 
increase in Myc tag expression. Out of 30 clones that were tested individually, 14 clones 
showed positive expression of Myc tag. 11 of these 14 clones were found to be unique 
clones, including B10 and C3 that were originally isolated by phage display. Anti-Myc 
antibody binding of newly isolated 9 clones was in the range of 10-19 MFI units, which 
is lower than B8 binding to A-LC (Myc expression of 4 selected clones are shown in Fig. 
3b). Overall, anti-B-LC VHHs isolated by the phage display and YS2H were low affinity 
binders (KD > 100 nM), suggesting a lack of the high affinity binders to B-LC protease in 
alpaca immune library.
Sequence analysis of the VHHs identified by phage or YS2H has shown that 
VHHs contain two to six cysteines, which would result in up to two extra disulfide bonds 
in addition to the one that is conserved in all immunoglobulin fold domains. (Fig. 3c).
We found that out of the nine VHHs newly isolated by our YS2H system, three contain 
six cysteines and the remainder contain four cysteines while phage-isolated VHHs 
contain two to four cysteines. The VHHs identified by a phage display system may be 
limited to those that fold properly in a bacterial expression system. VHHs containing 
extra disulfides may fold improperly in bacteria, while the formation of correct disulfide 
bonds is much less problematic in yeast. 
To confirm that the level of Myc expression correlates with the solution affinity 
of VHH to LC, we used a surface plasmon resonance (SPR) technique (Fig. 3d-e). A 
series of 2-fold dilutions of A-LC was injected into a chip coated with B8 and G6. A 
first-order Langmuir adsorption equation was fitted to the sensograms to obtain the 
kinetic and equilibrium binding constants. The equilibrium dissociation constants (KD) of 
B8 and G6 to BoNT/A-LC were estimated to be 2.3 nM and 230 nM, respectively. The 
100-fold difference in the affinity was mainly due to the 34-fold difference in the 
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Likewise, we measured the affinity of B-LC to C3 and VHH57, which exhibited 
equilibrium binding constant of 2.1 and 1.4 μM, respectively, which is consistent with the 
expression of Myc tags that showed slightly higher level in VHH57 than in C3 and lower 
binding than in B8 or G6. 
In summary, we demonstrated that protein-protein interactions that occur in the 
eukaryotic secretory pathway can be quantitatively detected using a novel YS2H system. 
It is important to note a highly quantitative aspect of the detection of Myc tag in 
predicting the affinity of antibodies to antigens. The expression of Myc tags in the 
binding of AL-57, TS1/22, and VHH-B8 to their respective antigens was in the range of 
13-50 MFI, which corresponds to 1 nM-1 μM KD predicted from the association of acid 
base coils. This estimation is consistent with a previous measurement of AL-57 binding 
to the HA I domain
25
 (KD =23 nM) and our measurement of B8 binding to BoNT/A-LC 
(KD = 2.3 nM). The expression of Myc tag in G6 was lower and is in agreement with the 
SPR measurement of KD = 230 nM. The quantitative aspect of YS2H was proven to be 
extremely powerful in exploring the nature of antibody recognition of antigen and 
activation allostery, and in the discovery of antibodies against bacterial toxins obviating 
the need to express soluble antigens.  
Methods.
YS2H vector design. The details of the YS2H vector design as well as the primers used 
to subclone acid/base coils, LFA-1 I domain, antibodies (AL-57, TS1/22, and VHHs), 
and BoNT/A-LC and B-LC into the YS2H are described in Supplementary Materials.
The cDNA coding for the variable domains of AL-57 was obtained from the expression 
plasmid (a kind gift from Dr. Shimaoka at Harvard Medical School). The variable 
domains of TS1/22 were cloned from the hybridoma (ATCC). VH and VL cDNAs were 
connected with four repeats of a Gly-Gly-Gly-Gly-Ser linker sequence to produce scFv.
Yeast transformation, MACS sorting, and library construction. A mutagenesis 
library of LFA-1 I domain was constructed by electroporation of a mixture of a 
MluI/NcoI linearized vector and error-prone PCR products of the I domain (Asn-129-
Thr-318) into yeast, as described previously
22
. To construct the VHH yeast library, a 
cDNA library was first inserted into the YS2H vector using NheI/BamHI sites by enzyme 
ligation. Yeast cells were then transformed with the plasmids using a lithium acetate 
method (Supplementary Materials). Library construction by homologous recombination 
or the lithium acetate method produced a library size of greater than 10
6
. The libraries of 




Immunofluorescence flow cytometry. Antibodies used in this study were the anti-c-
Myc antibody 9E10 (ATCC), anti-Flag, and phycoerythrin-labeled goat polyclonal anti-
murine antibodies (Santa Cruz Biotechnology, CA). After incubation, cells were 
harvested, washed in 100 μl of the labeling buffer (PBS with 0.5% BSA), and then 
incubated with ligands at 10 μg/ml in 50 μl of the labeling buffer for 20 min with shaking 
at 30 °C. Cell were then washed and incubated with secondary antibodies at 5 μg/ml in 
50 μl of the labeling buffer for 20 min at 4 °C. Finally, cells were washed once in 100 μl 
and suspended in 100 μl of the labeling buffer for flow cytometry (FACScan, BD 
Biosciences). For detecting TS1/22 binding (Fig. 2b), polyclonal goat antibody was used 
as a primary antibody. To induce dissociation of TS1/22 bound to the cell surface, 1 ml 
culture of yeast cells were incubated for 15 min in 200 μl of 10 mM Tris-glycine, pH 2.0 
(dissociation buffer). After centrifugation to pellet the cells, the supernatant was 
neutralized by addition of 10% v/v 1 M Tris, pH 8.0 (neutralization buffer). 50 μl of 
neutralized supernatant was then added to the 50 μl culture of cells, and anti-Myc 
antibody binding was examined.
BoNT/LC and VHH expression. Full-length BoNT/A and BoNT/B-LC encoding DNA 
(amino acids 1-448 of A-LC and 1-440 of B-LC) were synthesized employing codons 
optimal for expression in E. coli. A-LC and B-LC containing hexa-histidine tags at both 
termini were produced using a pET14b vector (manuscript in preparation). To express 
VHHs in soluble forms, we inserted VHH cDNA into the pET20b expression vector 
(Novagen). Soluble VHH was expressed in E. coli BL21 DE3 (Invitrogen), extracted by 
sonication, and purified using a Nickel nitrilo-triacetic acid (NTA) column. Eluted VHHs 
were then injected into an S75 size exclusion column connected to an FPLC (GE 
Healthcare) for further purification. 
SPR analysis. A VHH-coupled or mock-coupled CM5 sensor chip as a control was 
prepared using an amine coupling kit (BIAcore, Piscataway, NJ), as described previously 
22
. SPR was measured using a Biacore (BIA2000). VHHs were injected over the chip in 
20 mM Tris HCl, pH 8.0, 150 mM NaCl at a flow rate of 10 μl/min at room temperature. 
The chip surface was regenerated by flowing 20 μl of 10 mM Tris-glycine, pH 1.5 buffer.
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Figure Legends.
Figure 1 The design of the YS2H and its validation using coiled coil interactions. (a-b)
Schematic diagrams of the expression cassette and protein-protein interactions via the 
secretory pathway are depicted. The prey bound to the bait is detected by antibody 
binding to the Myc tag (a) or by direct GFP readout from split GFP complementation (b). 
Flag and Myc tags are fused to the C-terminal of the bait and prey proteins, respectively, 
and are used to measure the surface expression of the bait and the amount of the prey that 
is bound to the bait. (c) A schematic diagram (adapted from the Figure 1 by De 
Crescenzo et al
17
) of the acid (En)-base (Kn) coiled coils with ‘n’ indicates the number of 
heptad repeats. (d) The detection of coiled coil interactions by antibody binding to Myc 
tag (first and third columns) or direct GFP readout (second column) using flow 
cytometry. Numbers in each plot indicate mean fluorescence intensity (MFI). Thin and 
thick lines represent the histrograms of uninduced and induced clones, respectively. The 
pairs of bait and prey are denoted for each column as bait:prey. (e) Shown is the plot of 
the MFI of either Myc tag expression or GFP readout vs. the affinity of acid-base coils 
measured using SPR by De Crescenzo et al
17
. (f) Detection of acid-base coiled coil 
interaction by direct readout of OPT-GFP complementation. ‘K3’ indicates that K3 is 
fused to the N-OPT-GFP while no acid coil is fused to the C-OPT-GFP. OPT-GFP was 
split after either 7 strand (1-7-11) or 10 strand (1-10-11).
Figure 2. Detection of specific interactions between antibodies and antigens using YS2H. 
(a) Schematic diagram of the expression cassette used to study antigen (bait) and 
antibody (prey) interactions. (b) Shown are the flow cytometry histograms of the
interactions of the wild-type and the high affinity (HA) I domains as baits and activation-
specific antibody, AL-57 and activation-insensitive antibody, TS1/22 as preys. Thick 
lines are the histograms of the antibody binding to Myc and Flag tags to the induced 
clones that were labeled in the presence of 10 mM MgCl2 (black) or with no MgCl2 and 
10 mM EDTA (red) in the labeling buffer. Thin black lines represent antibody binding to 
uninduced clones as controls. (c) A histogram is shown for the amount of TS1/22 bound 
to the wild-type I domain (black) and the rebinding of eluted TS1/22 to the wild-type I 
domain (red). (d) Isolation of allosteric activation mutations in the LFA-1 I domain from 
the library after twice sorting using MACS with anti-Myc antibody.
Figure 3. Detection of VHH binding to BoNT LC protease. The binding of the VHHs 
isolated by phage display (a) and by YS2H (b) is measured by antibody binding to the 
Myc tag. Cysteines are highlighted in yellow for the pair that forms a conserved disulfide 
bond or in orange that may form extra disulfide bonds. The framework region (FR) and 
complementarity determining regions (CDR) are noted. (d-e). SPR measurements of B8 
(d) and G6 (e) to BoNT/A-LC. A-LC was injected at a series of 2-fold dilutions 
beginning at 160 nM to the B8- and 400 nM to the G6-coated chip.
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